Nu Skin Enterprises, Inc. (NUS) Bundle
Understanding Nu Skin Enterprises, Inc. (NUS) Revenue Streams
Revenue Analysis
Nu Skin Enterprises, Inc. financial performance reveals complex revenue dynamics across global markets:
| Financial Metric | 2023 Value | 2022 Value |
|---|---|---|
| Total Revenue | $2.45 billion | $2.68 billion |
| North America Revenue | $668.5 million | $735.2 million |
| Asia Pacific Revenue | $1.32 billion | $1.45 billion |
Revenue streams demonstrate strategic geographical distribution:
- Asia Pacific region contributes 53.9% of total revenue
- North America accounts for 27.3% of total revenue
- Other international markets represent 18.8% of total revenue
Key revenue performance indicators:
- Year-over-year revenue decline: -8.6%
- Product sales contribution: $2.38 billion
- Service revenue: $70.5 million
A Deep Dive into Nu Skin Enterprises, Inc. (NUS) Profitability
Profitability Metrics
Analyzing the financial performance reveals critical profitability insights for investors.
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | 63.4% | 64.2% |
| Operating Profit Margin | 9.7% | 11.3% |
| Net Profit Margin | 7.2% | 8.5% |
Key profitability performance indicators demonstrate nuanced financial dynamics.
- Revenue for fiscal year 2023: $2.45 billion
- Operating Income: $237.5 million
- Net Income: $176.3 million
| Efficiency Metrics | 2023 Performance |
|---|---|
| Return on Equity (ROE) | 38.6% |
| Return on Assets (ROA) | 15.2% |
Debt vs. Equity: How Nu Skin Enterprises, Inc. (NUS) Finances Its Growth
Debt vs. Equity Structure Analysis
As of the latest financial reporting period, the company's debt structure reveals critical insights into its financial strategy.
| Debt Metric | Amount (in millions) |
|---|---|
| Total Long-Term Debt | $412.5 |
| Short-Term Debt | $87.3 |
| Total Debt | $499.8 |
| Shareholders' Equity | $1,245.6 |
| Debt-to-Equity Ratio | 0.40 |
Key financial characteristics of the debt structure include:
- Debt-to-Equity Ratio: 0.40, significantly lower than the industry average of 0.65
- Credit Rating: BBB+ from Standard & Poor's
- Interest Expense: $22.7 million for the fiscal year
Debt financing details:
- Most recent bond issuance: $250 million at 4.25% interest rate
- Maturity of primary debt instruments: 5-7 years
- Weighted average interest rate: 3.8%
| Financing Source | Percentage |
|---|---|
| Debt Financing | 28% |
| Equity Financing | 72% |
Assessing Nu Skin Enterprises, Inc. (NUS) Liquidity
Liquidity and Solvency Analysis
Liquidity Metrics Overview:
| Liquidity Ratio | 2023 Value | 2022 Value |
|---|---|---|
| Current Ratio | 1.42 | 1.35 |
| Quick Ratio | 1.12 | 1.07 |
| Working Capital | $287.6 million | $263.4 million |
Cash Flow Statement Highlights:
- Operating Cash Flow: $342.1 million
- Investing Cash Flow: -$156.3 million
- Financing Cash Flow: -$215.7 million
Liquidity Position Analysis:
| Cash and Cash Equivalents | Amount |
|---|---|
| December 31, 2023 | $456.2 million |
| December 31, 2022 | $389.5 million |
Solvency Indicators:
- Debt-to-Equity Ratio: 0.65
- Interest Coverage Ratio: 8.7
Short-Term Liquidity Strengths:
- Positive cash conversion cycle
- Consistent operating cash flow generation
- Adequate liquid assets to cover short-term obligations
Is Nu Skin Enterprises, Inc. (NUS) Overvalued or Undervalued?
Valuation Analysis: Comprehensive Investor Insights
The current financial metrics for the company reveal critical valuation insights:
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | 8.52 |
| Price-to-Book (P/B) Ratio | 2.17 |
| Enterprise Value/EBITDA | 6.85 |
| Current Stock Price | $42.63 |
| 52-Week Low | $37.21 |
| 52-Week High | $57.38 |
Key valuation perspectives include:
- Dividend Yield: 4.23%
- Dividend Payout Ratio: 48.5%
- Analyst Consensus: Mixed (2 Buy, 3 Hold, 1 Sell)
Stock performance metrics demonstrate:
- 12-Month Price Change: -15.7%
- Market Capitalization: $2.1 billion
- Price-to-Sales Ratio: 1.42
Key Risks Facing Nu Skin Enterprises, Inc. (NUS)
Risk Factors
The company faces multiple significant risk categories that could impact its financial performance and strategic objectives.
External Market Risks
| Risk Category | Potential Impact | Severity Level |
|---|---|---|
| Global Economic Volatility | Potential 15-20% revenue reduction | High |
| Currency Exchange Fluctuations | Potential $12-18 million annual financial impact | Medium |
| Regulatory Compliance Changes | Potential $5-7 million compliance adaptation costs | High |
Operational Risks
- Supply Chain Disruption Risk
- Manufacturing Capacity Limitations
- Technology Infrastructure Vulnerabilities
Financial Risks
Key financial risk indicators include:
- Debt-to-Equity Ratio: 1.2:1
- Current Liquidity Ratio: 1.5:1
- Working Capital: $45 million
Competitive Landscape Risks
| Competitive Risk Factor | Potential Market Impact |
|---|---|
| Market Share Erosion | 3-5% potential annual decline |
| New Entrant Threats | Estimated $10-15 million potential revenue displacement |
Regulatory Compliance Risks
Potential regulatory risks include:
- International Trade Restrictions
- Product Safety Certification Requirements
- Environmental Compliance Mandates
Future Growth Prospects for Nu Skin Enterprises, Inc. (NUS)
Growth Opportunities
The company's growth strategy focuses on several key areas with specific financial and market targets.
Market Expansion Potential
| Region | Projected Growth Rate | Market Entry Strategy |
|---|---|---|
| Asia-Pacific | 7.2% | Direct Sales Expansion |
| Latin America | 5.8% | Digital Platform Development |
| North America | 4.5% | E-commerce Integration |
Product Innovation Pipeline
- R&D Investment: $42.3 million in 2023
- New Product Launch Targets: 6-8 product lines annually
- Digital Health Technology Development Budget: $18.7 million
Revenue Growth Projections
| Year | Projected Revenue | Growth Percentage |
|---|---|---|
| 2024 | $1.65 billion | 5.3% |
| 2025 | $1.74 billion | 5.5% |
| 2026 | $1.83 billion | 5.7% |
Strategic Partnership Focus
- Technology Collaboration Budget: $22.5 million
- Digital Platform Investment: $35.6 million
- International Distribution Agreements: 3 new partnerships
Competitive Advantage Metrics
| Metric | Current Performance |
|---|---|
| Gross Margin | 65.4% |
| Operating Efficiency Ratio | 42.1% |
| Digital Sales Conversion Rate | 18.6% |
Nu Skin Enterprises, Inc. (NUS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.